Review
Open access
Sep 2026
Research Progress of Multicomponent Co-Loaded Nanomedicine Delivery Systems for Tumor Immunotherapy
Abstract Tumor immunotherapy has substantially advanced cancer treatment by activating or enhancing the antitumor immune response. However, tumor heterogeneity, the immunosuppressive tumor microenvironment (TME), and therapeutic resistance limit the efficacy of single-agent immunotherapy, making mechanistically complem...
Tian-Ying Sun, Chuang Liu, Jiang Zhu et al.
· International Journal of Nan... · 0 citations